Photophobia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cataract
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Recurrent erosion of cornea
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Recurrent urinary tract infection
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Accessory kidney
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Renal glomerular disease
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Corneal erosion
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Predominantly lower limb lymphedema
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Recurrent skin infections
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Spinalarachnoid cyst
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the musculature
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the pulmonary vasculature
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Glomerulopathy Assessment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Congenital musculoskeletal anomalies
|
0.300 |
Biomarker
|
group |
CTD_human |
The winged helix transcription factor MFH1 is required for proliferation and patterning of paraxial mesoderm in the mouse embryo.
|
9106663 |
1997 |
Cardiovascular Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis.
|
9409679 |
1997 |
Craniofacial Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis.
|
9409679 |
1997 |
Craniofacial Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
The winged helix transcription factor MFH1 is required for proliferation and patterning of paraxial mesoderm in the mouse embryo.
|
9106663 |
1997 |
Interrupted aortic arch
|
0.010 |
Biomarker
|
disease |
BEFREE |
MFH-1-deficient mice died embryonically and perinatally, and exhibited interrupted aortic arch and skeletal defects in the neurocranium and the vertebral column.
|
9409679 |
1997 |
Lymphedema distichiasis syndrome
|
0.800 |
Biomarker
|
disease |
CTD_human |
Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.
|
11078474 |
2000 |
Lymphedema distichiasis syndrome
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.
|
11078474 |
2000 |
Lymphedema distichiasis syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.
|
11078474 |
2000 |
Lymphedema distichiasis syndrome
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.
|
11078474 |
2000 |
Hydrops Fetalis
|
0.320 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.
|
11078474 |
2000 |
Distichiasis
|
0.200 |
Biomarker
|
disease |
BEFREE |
FOXC2 knockout mice display cardiovascular, craniofacial, and vertebral abnormalities similar to those seen in LD syndrome.
|
11078474 |
2000 |